STLN
Starling Oncology, Inc.
NASDAQ · Healthcare · Medical - Care Facilities · US
$5.93
−0.67%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 66.20x
- P/S forward
- 0.79x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -24.26x
- Price / sales
- 1.03x
- Price / cash flow
- 1842.57x
Enterprise value
- Enterprise value
- $667.7M
- EV / sales
- 1.14x
- EV / EBITDA
- -30.55x
- EV / EBIT
- -25.59x
- Market cap
- $604.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026